Strong Balance SheetA robust balance sheet with high equity and low leverage provides durable financial flexibility: it supports funding of portfolio transactions, cushions downturns, and reduces refinancing risk, enabling sustained capital allocation to strategic investments and distributions.

Healthy Profitability & MarginsSustained gross and operating margins indicate effective cost management and profitable portfolio composition. Margin resilience improves internal cash generation potential and supports long-term return of capital or reinvestment even if top-line growth fluctuates.

Improving Cash GenerationA recent shift to positive operating cash flow and improving free cash flow suggest better cash conversion, which is fundamental for durable dividend capacity, funding selective exits or bolt-on investments, and lowering reliance on external financing.

Bears Say

Cash Flow VolatilityVolatile operating and free cash flows create uncertainty in funding ongoing operations, dividend sustainability, and the ability to support portfolio companies. This volatility can force reliance on asset sales or external financing, adding execution risk.

Revenue Volatility & Recent DeclineSignificant revenue swings and a recent drop undermine predictability of earnings and valuations of holdings. For a holding company, unstable top-line performance complicates cash planning and reduces visibility on distributable earnings over the medium term.

Holding Structure & Small ScaleAs a small-scale investment holding, the company depends on returns from portfolio companies and external managers. Limited operational footprint and concentration risk reduce direct control over outcomes and increase sensitivity to individual asset performance.

93M1 FAQ

What was MPH Health Care AG’s price range in the past 12 months?

MPH Health Care AG lowest stock price was €15.80 and its highest was €29.40 in the past 12 months.

What is MPH Health Care AG’s market cap?

MPH Health Care AG’s market cap is €93.76M.

When is MPH Health Care AG’s upcoming earnings report date?

MPH Health Care AG’s upcoming earnings report date is Apr 16, 2026 which is in 57 days.

How were MPH Health Care AG’s earnings last quarter?

Currently, no data Available

Is MPH Health Care AG overvalued?

According to Wall Street analysts MPH Health Care AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MPH Health Care AG pay dividends?

MPH Health Care AG pays a Annually dividend of €1.2 which represents an annual dividend yield of 5.31%. See more information on MPH Health Care AG dividends here

What is MPH Health Care AG’s EPS estimate?

MPH Health Care AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MPH Health Care AG have?

MPH Health Care AG has 4,281,384 shares outstanding.

What happened to MPH Health Care AG’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of MPH Health Care AG?

Currently, no hedge funds are holding shares in DE:93M1

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MPH Health Care AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

-43.43%

Trailing 12-Months

Asset Growth

-36.32%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MPH Health Care AG

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.